Accès gratuit
Med Sci (Paris)
Volume 20, Numéro 8-9, Août-Septembre 2004
Page(s) 773 - 778
Section M/S revues
Publié en ligne 15 août 2004
  1. Brady AE, Limbird LE. G protein-coupled receptor interacting proteins : Emerging roles in localization and signal transduction. Cell Signal 2002; 14 : 297–309.
  2. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors : Molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocrinol Rev 1996; 17 : 533–85.
  3. Dennis T, Fournier A, Cadieux A, et al. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther 1990; 254 : 123–8.
  4. Quirion R, Van Rossum D, Dumont Y, et al. Characterization of CGRP1 and CGRP2 receptor subtypes. Ann NY Acad Sci 1992; 657 : 88–105.
  5. Chakravarty P, Suthar TP, Coppock HA, et al. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity-modifyng proteins (RAMPs) in rat tissues. Br J Pharmacol 2000; 130 : 189–95.
  6. Wimalawansa SJ. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin : A peptide superfamily. Crit Rev Neurobiol 1997; 11 : 167–239.
  7. Nandha KA, Taylor GM, Smith DM, et al. Specific adrenomedullin binding sites and hypotension in the rat systemic vascular bed. Regul Pept 1996; 62 : 145–51.
  8. McLatchie L, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin receptor like receptor. Nature 1998; 393 : 333–9.
  9. Evans BN, Rosenblatt MI, Mnayer LO, et al. CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 2000; 275 : 31438–43.
  10. Luebke AE, Dahl GP, Roos BA, Dickerson IM. Identification of a protein that confers CGRP responsiveness to oocytes using CFTR assay. Proc Natl Acad Sci USA 1996; 93 : 3455–60.
  11. Prado MA, Evans-Bain B, Oliver KR, Dickerson IM. The role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction. Peptides 2001; 22 : 1773–81.
  12. Prado MA, Evans-Bain B, Dickerson IM. Receptor component protein (RCP) : A member of a multi-protein complex required for G-protein-coupled signal transduction. Biochem Soc Trans 2002; 30 : 460–4.
  13. Naghashpour M, Dahl G. Sensitivity of myometrium to CGRP varies during mouse estrous cycle and in response to progesterone. Am J Physiol Cell Physiol 2000; 278 : C561–9.
  14. Njuki F, Nicholl CG, Howard A, et al. A new calcitonin-receptor-like sequence in rat pulmonary blood vessels. Clin Sci 1993; 85 : 385–8.
  15. Edvinsson L, Sams A, Jansen-Olesen I, et al. Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol 2001; 415 : 39–44.
  16. Chauhan M, Thota CS, Kondapaka S, et al. Evidence for the existence of a new receptor for CGRP, which is not CRLR. Peptides 2003; 24 : 65–71.
  17. Sexton PM, Albiston A, Morfis M, Tilakaratne N. Receptor activity modifying proteins. Cell Signal 2001; 13 : 73–83.
  18. Buhlmann N, Aldeoca A, Leuthauser K, et al. Glycosylation of the calcitonin receptor like receptor at Asn(60) or Asn(112) is important for cell surface expression. FEBS Lett 2000; 486 : 320–4.
  19. Flahaut M, Rossier BC, Firsov D. Respective roles of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMP) in cell surface expression of CRLR/RAMP heterodimeric receptors. J Biol Chem 2002; 277 : 14731–7.
  20. Christopoulos G, Perry KJ, Morfis M, et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 1999; 56 : 235–42.
  21. Christopoulos A, Christopoulos G, Morfis M, et al. Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 2003; 278 : 3293–7.
  22. Poyner DR, Sexton PM, Marshall I, et al. International union of pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002; 54 : 233–46.
  23. Armour SL, Foord S, Kenakin T, Chen WJ. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. J Pharmacol Toxicol Meth 1999; 42 : 217–24.
  24. Muff R, Buhlmann N, Fisher JA, Born W. An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying protein. Endocrinology 1999; 140 : 2924–27.
  25. Kuwasako K, Kitamura K, Nagoshi Y, Eto T. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity. J Biol Chem 2003; 278 : 22623–30.
  26. Foord SM, Marshall FH. RAMPs : Accessory proteins for seven transmembrane domain receptors. Trends Pharmacol Sci 1999; 20 : 184–7.
  27. Aldecoa A, Gujer R, Fisher JA, Born W. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells. FEBS lett 2000; 471 : 156–60.
  28. Hilairet S, Foord SM, Marshall FH, Bouvier M. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins. J Biol Chem 2001; 276 : 29575–81.
  29. Gujer R, Aldecoa A, Buhlmann N, et al. Mutations of the asparagine 117 residue of a receptor activity-modifying protein 1 dependent human calcitonin gene-related peptide receptor result in selective loss of function. Biochemistry 2001; 40 : 5392–8.
  30. Kuwasako K, Kitamura K, Ito K, et al. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors. J Biol Chem 2001; 276 : 49459–65.
  31. Tilakaratne N, Christopoulos G, Zumpe ET, et al. Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J Pharmacol Exp Ther 2000; 294 : 61–72.
  32. Totsune KO, Takahashi K, Mackenzie HS, et al. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the heart of rats with congestive heart failure. Clin Sci 2000; 99 : 541–6.
  33. Oie E, Vinge LE, Yndestad A, et al. Induction of a myocardial adrenomedullin signalling system during ischemic heart failure in rats. Circulation 2000; 101 : 415–22.
  34. Cueille C, Pidoux E, De Vernejoul MC, Garel JM. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun 2002; 294 : 340–6.
  35. Nagae T, Mukoyama M, Sugawara A, et al. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor : Cloning and upregulation in obstructive nephropathy. Biochem Biophys Res Commun 2000; 270 : 89–93.
  36. Ono Y, Okano I, Kojima M, et al. Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem Biophys Res Commun 2000; 271 : 197–202.
  37. Qing X, Svaren J, Keith IM. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am J Physiol Lung Cell Mol Physiol 2001; 280 : L547–54.
  38. Frayon S, Cueille C, Gnidéhou S, et al. Dexamethasone increases RAMP1 and CRLR mRNA expressions in human vascular smooth muscle cells. Biochem Biophys Res Commun 2000; 270 : 1063–7.
  39. Makino Y, Shibata K, Makino I, et al. Alteration of the adrenomedullin receptor component gene expression associated with the blood pressure in pregnancy-induced hypertension. J Clin Endocrinol Metab 2001; 86 : 5079–82.
  40. Nowak W, Parameswaran N, Hall CS, et al. Novel regulation of adrenomedullin receptor by PDGF : Role of receptor activity modifying. Am J Physiol Cell Physiol 2002; 282 : C1322–31.
  41. Roh J, Chang CL, Bhalla A, et al. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 2004; 279 : 7264–74.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.